High-level expression and characterization of single chain urokinase-type plasminogen activator (scu-PA) produced in recombinant Chinese hamster ovary (CHO) cells

Biotechnology and Bioprocess Engineering

Volumn 6, Issue 2, 2001, Pages 117-127

  Kim, Jung Seob ^a   Min, Mi Kyung ^a   Jo, Eui Cheol ^a  

^a Mogam Biotechnology Research Institute   (South Korea)

Author keywords

CHO cells; Copy number; Gene amplification; MTX; pro UK; Scu PA

Indexed keywords

EID: 33748487012     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931957     Document Type: Article

References (67)

1. Stump, D. C., M. Thienpont, and D. Collen (1986) Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (prouroki-nase) and urokinase-inhibitor complex. J. Biol. Chem. 261: 1267-1273.
2. Kasai, S., H. Arimura, M. Nishida, and T. Suyama (1985) Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. J. Biol. Chem. 260: 12377-12381.
3. Weaver, W. D., J. R. Hartmann, J. L. Anderson, P. S. Reddy, J. C. Sobolski, and A. A. Sasahara (1994) New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group. J. Am. Coll. Cardiol. 24: 1242-1248.
4. Ouriel, K., C. K. Shortell, J. A. DeWeese, R. M. Green, C. W. Francis, M. V. Azodo, O. H. Gutierrez, J. V. Manzione, C. Cox, and V. J. Marder (1994) A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J. Vasc. Surg. 19: 1021-1030.
5. Wun, T. C., L. Ossowski, and E. Reich (1982) A proenzyme form of human urokinase. J. Biol. Chem. 257: 7262-7268.
6. Gunzler, W. A., G. J. Steffens, F. Otting, S. M. Kim, E. Frankus, and L. Flohe (1982) The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain. Hoppe-Seyler's Z. Physiol. Chem. 363: 1155-1165.
7. Novokhatny V., L. Medved, A. Mazar, P. Marcotte, J. Henkin, and K. Ingham (1992) Domain structure and interactions of recombinant urokinase-type plasminogen activator. J. Biol. Chem. 267: 3878-3885.
8. Husain, S. S., V. Gurewich, and B. Lipinski (1983) Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine. Arch. Biochem. Biophys. 220: 31-38.
9. Ichinose, A., K. Fujikawa, and T Suyama (1986) The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J. Biol. Chem. 261: 3486-3489.
10. Kobayashi, H, M. Schmitt, L. Goretzki, N. Chucholowski, J. Calvete, M. Kramer, W. A. Gunzler, F. Janicke, and H. Graeff (1991) Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J. Biol. Chem. 266: 5147-5152.
11. Loza, J. P., V. Gurewich, M. Johnstone, and R. Pannell (1994) Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. Thromb. Haemost. 71: 347-352.
12. Gurewich, V., R. Pannell, S. Louie, P. Kelley R. L. Suddith, and R. Greenlee (1984) Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (prourokinase). A study in vitro and in two animal species. J. Clin. Invest. 73: 1731-1739.
13. Zamarron, C., H. R. Lijnen, B. Van Hoef, and D. Collen (1984) Biological and thrombolytic properties of proenzyme and active forms of human urokinase: I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology. Thromb. Haemost. 52: 19-23.
14. Liu, J. N. and V. Gurewich (1992) Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK. Biochemistry 31: 6311-6317.
15. Collen, D., J. M. Stassen, M. Blaber, M. Winkler, and M. Verstraete (1984) Biological and thrombolytic properties of proenzyme and active forms of human urokinase: III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis. Thromb. Haemost. 52: 27-30.
16. Van de Werf, F., I. K. Jang, and D. Collen (1987) Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis. J. Cardiovasc. Pharmacol. 9: 91-93.
17. Kido, H., K. Hayashi, T. Uchida, and M. Watanabe (1995) Low incidence of hemorrhagic infarction following coronary reperfusion with nasaruplase in a canine model of acute myocardial infarction. Comparison with recombinant t-PA. Jpn. Heart J. 36: 61-79.
18. Credo, R. B., J. C. Sobolski, W. D. Weaver, and J. R. Hartmann (1997) Recombinant glycosylated pro-urokinase: biochemistry, pharmacology, and early clinical experience. pp. 561-589. In: Sasahara, A. A., and J. Loscalzo (eds.). New Therapeutic Agents in Thrombosis and Thromobolysis. Marcel Dekker, NY, USA.
19. Gurewich, V., M. Johnstone, J. P. Loza, and R. Pannell (1993) Pro-urokinase and prekallikrein are both associated with platelets. Implications for the intrinsic pathway of fibrinolysis and for therapeutic thrombolysis. FEBS Lett. 318: 317-321.
20. Wun, T. C., W. D. Schleuning, and E. Reich (1982) Isolation and characterization of urokinase from human plasma. J. Biol. Chem. 257: 3276-3283.
21. Nielsen, L. S., J. G. Hansen, L. Skriver, E. L. Wilson, K. Kaltoft, J. Zeuthen, and K. Dano (1982) Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry 21: 6410-6415.
22. Yoshimoto, M., Y. Ushiyama, M. Sakai, S. Tamaki, H. Hara, K. Takahashi, Y. Sawasaki, and K. Hanada (1996) Characterization of single chain urokinase-type plasminogen activator with a novel amino-acid substitution in the kringle structure. Biochim. Biophys. Acta. 1293: 83-89.
23. Kasai, S., H. Arimura, M. Nishida, and T. Suyama (1985) Primary structure of single-chain pro-urokinase. J. Biol. Chem. 260: 12382-12389.
24. Nagai, M., R. Hiramatsu, T. Kaneda, N. Hayasuke, H. Arimura, M. Nishida, and T. Suyama (1985) Molecular cloning of cDNA coding for human preprourokinase. Gene 36: 183-188.
25. Jacobs, P., A. Cravador, R. Loriau, F. Brockly B. Colau, P. Chuchana, A. van Elsen, A. Herzog, and A. Bollen (1985) Molecular cloning, sequencing, and expression in Escherichia coli of human preprourokinase cDNA. DNA 4: 139-146.
26. Riccio, A., G. Grimaldi, P. Verde, G. Sebastio, S. Boast, and F. Blasi (1985) The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res. 13: 2759-2771.
27. Patthy L. (1990) Evolutionary assembly of blood coagulation proteins. Semin. Thromb. Hemost. 16: 245-259.
28. Brigelius-Flohe, R., G. Steffens, W. Strassburger, and L. Flohe (1992) High expression vectors for the production of recombinant single-chain urinary plasminogen activator from Escherichia coli. Appl. Microbiol. Biotechnol. 36: 640-649.
29. Melnick, L. M., B. G. Turner, P. Puma, B. Price-Tillotson, K. A. Salvato, D. R. Dumais, D. T. Moir, R. J. Broeze, and G. C. Avgerinos (1990) Characterization of a nonglycosylated single chain urinary plasminogen activator secreted from yeast. J. Biol. Chem. 265: 801-807.
30. Nelles, L., H. R. Lijnen, D. Collen, and W. E. Holmes (1987) Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158. J. Biol. Chem. 262: 5682-5689.
31. Avgerinos, G. C., D. Drapeau, J. S. Socolow, J. I. Mao, K. Hsiao, and R. J. Broeze (1990) Spin filter perfusion system for high density cell culture: production of recombinant urinary type plasminogen activator in CHO cells. Bio/Technol. 8: 54-58.
32. Satoh, M., S. Hosoi, H. Miyaji, S. Itoh, and S. Sato (1993) Stable production of recombinant pro-urokinase by human lymphoblastoid Namalwa KJM-1 cells: host-cell dependency of the expressed-protein stability. Cytotechnology 13: 79-88.
33. Zang, M., H. Trautmann, C. Gandor, F. Messi, F. Asselbergs, C. Leist, A. Fiechter, and J. Reiser (1995) Production of recombinant proteins in Chinese hamster ovary cells using a protein-free cell culture medium. Bio/Tech-nol. 13: 389-392.
34. Mathey D. G., J. Schofer, K. H. Kuck, U. Beil, and G. Kloppel (1982) Transmural, haemorrhagic myocardial infarction after intracoronary streptokinase. Clinical, angiographic, and necropsy findings. Br. Heart J. 48: 546-551.
35. Bang, N. U. (1989) Tissue-type plasminogen activator mutants. Theoretical and clinical considerations. Circulation 79: 1391-1392.
36. Tebbe, U., W. A. Gunzler, G. R. Hopkins, T. Grymbowski, and H. Barth (1997) Thrombolytic therapy of acute myocardial infarction with saruplase, a single-chain urokinase-type plasminogen activator (scu-PA) from recombinant bacteria. Fibrinol. Proteolysis 11: 45-54.
37. Collen, D., D. Stump, F. van de Werf, I. K. Jang, M. Nobuhara, and H. R. Lijnen (1985) Coronary thrombolysis in dogs with intravenously administered human prourokinase. Circulation 72: 384-388.
38. Urlaub, G. and L. A. Chasin (1980) Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci. USA 77: 4216-4220.
39. Kaufman, R. J. and P. A. Sharp (1982) Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene. J. Mol. Biol. 159: 601-621.
40. Kaufman, R. J., L. C. Wasley A. J. Spiliotes, S. D. Gossels, S. A. Latt, G. R. Larsen, and R. M. Kay (1985) Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells. Mol. Cell. Biol. 5: 1750-1759.
41. Gralnick, H. R., S. B. Williams, and M. E. Rick (1983) Role of carbohydrate in multimeric structure of factor VHI/von Willebrand factor protein. Proc. Natl. Acad. Sci. USA 80: 2771-2774.
42. Goto, M., K. Akai, A. Murakami, C. Hashimoto, E. Tsuda, M. Ueda, G. Kawanishi, N. Takahashi, A. Ishimoto, H. Chiba, and R. Sasaki (1988) Production of recombinant human erythropoiwtin in mammalian cells: host-cell dependency of biological activity of the cloned glycoprotein. Bio/Technol. 6: 67-71.
43. Kaufman, R. J. (1990) Selection and coamplification of heterologous genes in mammalian cells. Methods Enzymol. 185: 537-566.
44. Page, M. J. and M. A. Sydenham (1991) High level expression of the humanized monoclonal antibody Campath-1H in Chinese hamster ovary cells. Bio/Technol. 9: 64-68.
45. Park, B. G., J. M. Chun, G. T. Lee, I. H. Kim, and Y. H. Jeong (2000) Development of high density mammalian cell culture system for the production of tissue-type plasminogen. Biotechnol. Bioprocess Eng. 5: 123-129.
46. Kaufman, R. J. and R. T. Schimke (1981) Amplification and loss of dihydrofolate reductase genes in a Chinese hamster ovary cell line. Mol. Cell. Biol. 1: 1069-1076.
47. Stark, G. R., M. Debatisse, E. Giulotto, and G. M. Wahl (1989) Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57: 901-908.
48. Kim, S. J., N. S. Kim, C. J. Ryu, H. J. Hong, and G. M. Lee (1998) Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. Biotechnol. Bioeng. 58: 73-84.
49. Urlaub, G., E. Kas, A. M. Carothers, and L. A. Chasin (1983) Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 33: 405-412.
50. Kim, H. G., K. D. Sung, M. S. Ham, K. H. Chung, K. H. Chung, and H. Y. Lee (1995) The optimization of serum-free medium for the production of the scu-PA by the addition of algal extracts. Cytotechnology 17: 165-172.
51. Jo, E. C., J. W. Yun, S. I. Jung, K. H. Chung, and J. H. Kim (1998) Performance study of perfusion cultures for the production of single-chain urokinase-type plasminogen activator (scu-PA) in a 2.5 L spin-filter bioreactor. Bioproc. Eng. 19: 363-372.
52. Venolia, L., G. Urlaub, and L. A. Chasin (1987) Polyadenylation of Chinese hamster dihydrofolate reductase genomic genes and minigenes after gene transfer. Somat. Cell. Mol. Genet. 13: 491-504.
53. Melera, P. W., J. P. Davide, C. A. Hession, and K. W. Scotto (1984) Phenotypic expression in Escherichia coli and nucleotide sequence of two Chinese hamster lung cell cDNAs encoding different dihydrofolate reductases. Mol. Cell. Biol. 4: 38-48.
54. Mitchell, P. J., A. M. Carothers, J. H. Han, J. D. Harding, E. Kas, L. Venolia, and L. A. Chasin (1986) Multiple transcription start sites, DNase I-hypersensitive sites, and an opposite-strand exon in the 5′ region of the CHO dhfr gene. Mol. Cell. Biol. 6: 425-440.
55. Mohr, G., A. Preininger, M. Himmelspach, B. Plaimauer, C. Arbesser, H. York, F. Dorner, and U. Schlokat (2000) Permanent mycoplasma removal from tissue culture cells: a genetic approach. Biotechnol. Bioprocess Eng. 5: 84-91.
56. Kida, T., S. Fujishima, M. Matsumura, and P. C. Wang (2000) Immobilization of rat kidney glomerular mesangial cell and its coculture with glomerular epitherial cell. Biotechnol. Bioprocess Eng. 5: 92-98.
57. Kluft, C. (1979) Studies on the fibrinolytic system in human plasma: quantitative determination of plasminogen activators and proactivators. Thromb. Haemost. 41: 365-383.
58. Corti, A., M. L. Nolli, and G. Cassani (1986) Differential detection of single-chain and two-chain urokinase-type plasminogen activator by a new immunoadsorbent-amidolytic assay (IAA). Thromb. Haemost. 56: 407-410.
59. Lichter, P., A. L. Boyle, T. Cremer, and D. C. Ward (1991) Analysis of genes and chromosomes by nonisotopic in situ hybridization. Genet. Anal. Tech. Appl. 8: 24-35.
60. Satoh, M., S. Hosoi, and S. Sato (1990) Chinese hamster ovary cells continuously secrete a cysteine endopeptidase. In Vitro Cell. Dev. Biol. 26: 1101-1104.
61. Kaufman, R. J., L. C. Wasley and A. J. Dorner (1988) Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J. Biol. Chem. 263: 6352-6362.
62. Kentzer, E. J., A. Buko, G. Menon, and V. K. Sarin (1990) Carbohydrate composition and presence of a fucoseprotein linkage in recombinant human pro-urokinase. Biochem. Biophys. Res. Commun. 171: 401-406.
63. Lenich, C., R. Pannell, J. Henkin, and V. Gurewich (1992) The influence of glycosylation on the catalytic and fibrinolytic properties of pro-urokinase. Thromb. Haemost. 68: 539-544.
64. Stief, A., D. M. Winter, W. H. Stratling, and A. E. Sippel (1989) A nuclear DNA attachment element mediates elevated and position-independent gene activity. Nature 341: 343-345.
65. Klehr, D., K. Maass, and J. Bode (1991) Scaffold-attached regions from the human interferon beta domain can be used to enhance the stable expression of genes under the control of various promoters. Biochemistry 30: 1264-1270.
66. Dorer, D. R. and S. Henikoff (1994) Expansions of transgene repeats cause heterochromatin formation and gene silencing in Drosophila. Cell 77: 993-1002.
67. Kalos, M. and R. E. Fournier (1995) Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain. Mol. Cell. Biol. 15: 198-207.